The Center for Clinical Laboratories at The Mount Sinai Hospital offers a growing menu of molecular, immunologic, and biochemical laboratory tests for diagnostic and prognostic disease markers and risk factors, in support of personalized medicine. Available tests include:

• Blood test panels including molecular and biochemical tests to evaluate recognized risk factors associated with thrombosis (blood clotting) and thrombosis-related pregnancy loss.
• Pharmacogenomics to help predict a person's response to treatment with various drugs and to chose the best treatment/dosing plan
• Blood tests to evaluate a person's sensitivity to blood thinners such as aspirin and/or clopidogrel (Plavix), directed against platelets
• Molecular studies, as well as conventional and molecular cytogenetic (FISH) tests for hematological malignancies (cancers of the blood), bladder cancer, and brain cancer to assess prognosis and choose appropriate treatment.
• Molecular HLA typing to determine the presence of the HLA-B*5701 allele in HIV-infected patients to predict high risk of hypersensitivity to abacavir prior to therapy.

For further information please contact the Center for Clinical Laboratories at (212) 659-8181.